Clinical Trial Update: Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer's Disease, Vascular Dementia, and Mixed Vascular and Alzheimer's Dementia [Phase 4]

View source ↗

Summary

Phase 4 trial comparing escitalopram to placebo for depressive symptoms in patients with Alzheimer's disease, vascular dementia, or mixed dementia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Mixed Dementia
• Vascular Dementia

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: Sheba Medical Center | Conditions: Depressive Syndrome | Phase 4 | Status: UNKNOWN